This paper is a report on a pilot study designed to test the hypothesis that with a negative node status minimal surgery and conservation of the breast is indicated. The preliminary figures giving the recurrence rate and survival time tentatively suggest that this is true.
Introduction
In 1971 Crile made the tentative suggestion that a controlled, randomized clinical trial should be carried out to determine whether quadrantic excision of a small breast tumour was as effective, in terms of survival time, as a standard radical mastectomy. He suggested that if this showed no significant difference in the local recurrence rate and the overall survival time, it might be justifiable in certain cases to conserve the breast (Crile et al. 1973 , Esselstyn et al. 1975 .
No such trial would appear to have been undertaken in this country, probably because most clinicians have always considered that the local recurrence rate, either in the operation area, or in the axilla, would be so frequent and so early that it would be subjecting the patient to an unjustifiable and unethical risk.
This paper gives an account of 26 invasive carcinomas measuring less than 2 em treated by quadrantic excision and axi1lary dissection only. In all cases the axillary node status was negative. No other adjuvant therapy has been used. While the follow-up time is short and the number of cases small, the authors make no apology for this, since it was designed as a pilot study to test the hypothesis that a small tumour in an otherwise normal breast with negative axillary nodes carried such a favourable prognosis that minimal treatment with conservation of the breast was indicated.
Materials and methods
Twenty-six patients with carcinoma of the breast have been treated by quadrantic excision and axillary dissection.
The indications were as follows: (I) The tumour was located in the outer half of the breast and was less than 2 em in diameter when measured by the histopathologist in the excised specimen.
(2) On clinical examination there was no involvement of the skin overlying the I Accepted 17 February 1978 0141-0768/78/0071-0261/$01.00/0 tumour, with minimal tethering never measuring more than 2 ern. (3) The axillary lymph nodes were negative on clinical examination and this was confirmed by histology.
All patients were assessed pre-operatively by full blood count, ESR, liver function tests and X-rays of chest, lumbar spine and pelvis and since 1975 by bone and liver scans and urinary hydroxyproline.
Results
Table 1 details the age, menstrual status, pathology, survival time in months and the time at which recurrence occurred for all patients studied. Follow-up time is from 19-74 months with a mean of38.2 months. The ages ranged from 35-80 years with a mean of55.8 years, and 9 out of the 26 women were nulliparous. Sixteen patients were post-menopausal and 10 premenopausal.
There has been recurrence in the operation area in 4 cases (15 0 0 ) in the series: (1) A 42-year-old woman with intraduct, intralobular and infiltrating carcinoma (Grade III) had a recurrence at 15 months. Excision biopsy was performed and on frozen section an intraduct and infiltrating carcinoma (Grade III) was seen and mastectomy was therefore undertaken. She remains well with no sign of recurrence at 19 months.
(2) A 42-year-old pre-menopausal woman with infiltrating duct carcinoma (Grade III) had a recurrence at 14 months. Excision biopsy was performed and the histology showed an intraduct in-situ carcinoma. She remains well with no sign oflocal recurrence at 34 months.
(3) A 52-year-old pre-menopausal woman with infiltrating carcinoma (Grade II) had a recurrence at 36 months. Excision biopsy was performed and histology showed an infiltrating carcinoma (Grade II) and mastectomy was therefore carried out. She remains well, with no sign of recurrence at 42 months. (4) A 60-year-old post-menopausal woman with infiltrating duct carcinoma (Grade I) had a recurrence at 54 months. Excision biopsy was performed and histology showed infiltrating duct carcinoma (Grade I) in the scar. She remains well with no sign of local recurrence at 61 months.
In one patient (Case 25 in Table 1 ) the primary tumour was removed elsewhere one year prior to the staging axillary dissection. The histology report on the axillary lymph nodes is of interest: '13 small lymph nodes were found in the axillary fat. In two of these there are one or two isolated groups of degenerate carcinoma cells. These appear in general to be inert. Mitosis was not seen and the cells, although presumably viable, may well have been there for some considerable time.'
Patients have been assessed within the last six months with the following investigations: bone scan, chest X-ray, full blood count, liver function tests, ESR, carcino-embryonic antigen. In no case has evidence of disseminated disease been found.
There.has been one death in this series: the patient (Case 10) was killed in an air accident at 30 months.
Discussion
The literature abounds with statements which would disillusion the most ardent supporter of any treatment no matter how well planned or executed. 'It must be concluded therefore, that, because of very early remote spread via the blood stream in most, ifnot all, lethal breast cancer, neither early nor extensive treatment can materially prevent or postpone death from breast cancer' (McKinnon 1954) . 'It has been explained how variability in growth rate between different cancers combined with use of a survival rate as a measure of cure can create an apparent cure rate which is partly or wholly fictitious. From an analysis of the evidence it has been shown that the apparent curability of cancer of the breast can be explained entirely in terms of the variability of growth rate' (Park & Lees 1951) . Halsted (1891) devised the operation of radical mastectomy because he was disappointed with the high rate of local recurrence. The reason for this is clear, since many of the tumours must have been, by modern standards, beyond the scope of radical surgery. Involvement of the pectoralis major muscle was the indication that it should be removed and every attempt was made to go so far wide of the tumour that 'no tissue should be cut through that was already affected'. While the operation did reduce the rate of local recurrence, it did not significantly increase the survival time, and any improvements in the results of treatment over the last fifty years must be attributed to better selection of cases. Carefully planned and intensive prophylactic radiotherapy was then used either before or after radical surgery. This decreased the local recurrence rate, but again did not affect the survival time (Fisher 1977a , Stjernsward 1974 , 1977 . Conservative surgery with radiotherapy was advocated with no improvement in the five-year survival results (Atkins et al. 1972 , Murray 1974 . It has been suggested that following surgery or a combination of surgery and radiotherapy to control the primary tumour and the draining lymph nodes, cytotoxic drugs should be given to eliminate any minimal disseminated disease. It will not bepossible to assess the long-term results of these studies for at least another two years (Bonnadonna et al. 1976 , Veronesi et al. 1977 , Fisher 1977b , and this, indeed, may only show a prolonged disease-free interval.
On many occasions clinicians have observed with interest that following a radical mastectomy, the histopathologist has found no evidence of residual tumour or any other abnormality in the breast, and no deposits in the axillary lymph nodes. Was there any good reason to remove a 'normal' breast and uninvolved regional lymph nodes? Hard evidence is now needed to demonstrate that quadrantic excision of a small tumour in a normal breast with negative nodes is or is not followed by loco-regional recurrence and dissemination. It would now seem justifiable and ethical to organize a controlled trial of wide quadrantic excision and axillary dissection under the conditions described earlier, versus mastectomy and axillary dissection.
We must accept the evidence that breast cancer is in most, if not all, cases a systemic disease at the time of diagnosis. Surely, therefore, we should consider conserving the breast in those patients where the removal does not give an increased survival time or a lower recurrence rate.
